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ABSTRACT
BOWDENDAVIES, K. A., V. S. SPRUNG, J. A. NORMAN, A. THOMPSON, K. L. MITCHELL, J. A. HARROLD, G. FINLAYSON,
C. GIBBONS, J. P. H. WILDING, G. J. KEMP, M. HAMER, and D. J. CUTHBERTSON. Physical Activity and Sedentary Time:
Association with Metabolic Health and Liver Fat.Med. Sci. Sports Exerc., Vol. 51, No. 6, pp. 1169–1177, 2019. Introduction/Purpose:
To investigate whether (a) lower levels of daily physical activity (PA) and greater sedentary time accounted for contrasting metabolic
phenotypes (higher liver fat/presence of metabolic syndrome [METS+] vs lower liver fat/absence of metabolic syndrome [METSj]) in
individuals of similar body mass index and (b) the association of sedentary time on metabolic health and liver fat.Methods: Ninety-eight
habitually active participants (53 female, 45 male; age, 39 T 13 yr; body mass index 26.9 T 5.1 kgImj2), underwent assessments of PA
(SenseWear armband; wear time ~98%), cardiorespiratory fitness (V˙O2 peak), body composition (magnetic resonance imaging and magnetic
resonance spectroscopy) and multiorgan insulin sensitivity (oral glucose tolerance test). We undertook a) cross-sectional analysis comparing
four groups: nonobese or obese, with and without metabolic syndrome (METS+ vs METSj) and b) univariate and multivariate regression
for sedentary time and other levels of PA in relation to liver fat.Results: Light, moderate, and vigorous PA did not account for differences in
metabolic health between individuals, whether nonobese or obese, althoughMETS+ individuals were more sedentary, with a higher number,
and prolonged bouts (~1–2 h). Overall, sedentary time, average daily METS and V˙O2 peak were each independently associated with liver fat
percentage. Each additional hour of daily sedentary time was associated with a 1.15% (95% confidence interval, 1.14%–1.50%) higher liver
fat content. Conclusions: Greater sedentary time, independent of other levels of PA, is associated with being metabolically unhealthy; even
in habitually active people, lesser sedentary time, and higher cardiorespiratory fitness and average daily METS is associated with lower liver
fat. Key Words: BODY COMPOSITION, MAGNETIC RESONANCE SPECTROSCOPY, METABOLIC SYNDROME, INSULIN
REGULATION, CARDIORESPIRATORY FITNESS, METABOLIC EQUIVALENTS
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S
trong epidemiologic evidence suggests an inverse
relationship between physical activity (PA) levels and
obesity, metabolic syndrome (METS), nonalcoholic
fatty liver disease (NAFLD) and type 2 diabetes (1–5). In-
creased PA is recommended both for individuals and at a
population level to improve metabolic health and help
prevent these interrelated conditions. The independent
protective effect of high cardiorespiratory fitness (CRF),
an objective marker of PA, against all-cause mortality is
well established (6,7). There is a growing recognition that
sedentary behavior, which has an independent association
with adverse health outcomes, should be minimized
(2,8,9). Increasing moderate PA is protective against the
aforementioned diseases and attenuates, but does not
eliminate, the detrimental effects of sedentary behavior
(10). Breaking up prolonged periods of sedentary time (11)
or replacing it with low-intensity PA (12) are beneficial for
glycemic control.
Obesity is strongly associated with poor cardiometabolic
health and overall mortality (13). However, not all obese
individuals are metabolically unhealthy (METS+) (14);
conversely not all nonobese individuals are metabolically
healthy (METSj) (15). Some studies suggest that METS+
may be a consequence of low PA (16,17), but others have
not supported this conclusion (18–20). With differences in
methodology, cohort characteristics and definitions of
metabolic phenotypes, these studies typically have not
precisely defined the differences in PA characteristics be-
tween phenotypes. Only one study, of older adults, has
objectively measured sedentary behavior (19), which of-
fers better reliability than self-report (21); no such study
has been undertaken in young to middle-age adults. There
are similarly conflicting results in studies of the associa-
tion of metabolic health with objectively measured sed-
entary behavior and quantitative measures of liver fat
using magnetic resonance spectroscopy (MRS) or com-
puted tomography (22–26). The accumulation of liver fat
has been described as a major contributor to the develop-
ment of type 2 diabetes (27) and is considered the hepatic
manifestation of METS and closely linked with obesity
and insulin resistance (28). Observing levels of PA, in-
cluding sedentary behavior, in metabolic phenotypes of a
given body mass index (BMI) category with further
quantification of liver fat may reveal associations which
link habitual activity to health outcomes and the predis-
position for metabolic diseases.
This cross-sectional study will objectively monitor the
habitual PA of young to middle-age adults and extensively
phenotype these individuals by assessment of metabolic
health and magnetic resonance imaging (MRI)-derived
body composition. We hypothesize that greater sedentary
time and lower levels of PA will be evident in metabolically
unhealthy phenotypes (METS+ vs METSj) in BMI-
matched individuals; and second, higher MRS-quantified
liver fat will be associated with greater sedentary time and
lower PA levels.
METHODS
Participants
Habitually active individuals, who engaged in no more
than 2 h of exercise per week, were recruited via local ad-
vertisements across University of Liverpool campuses and
hospital departments. Exclusions included cardiovascular,
respiratory, kidney, liver and/or endocrine complications,
smoking, and 914 units per week of alcohol consumption.
The study conformed to the Declaration of Helsinki and was
approved by the North West Liverpool Central research ethics
committee (14/NW/1145; 14/NW/1147; 15/NW/0550). All
participants were informed of the methods verbally and in
writing before providing written informed consent before any
assessments. Ninety-eight individuals (52 male, 46 female)
with a mean age of 39 T 13 yr and BMI of 27 T 5 kgImj2 were
recruited. Before each study visit, participants were required
to fast overnight for 12 h (water was permitted ad libitum),
abstain from alcohol and caffeine for 24 h and from exercise
for 48 h.
Study Design
All participants completed measurement of baseline PA and
dietary consumption over a period of 4 d (including oneweekend
day) between January 2016 and February 2017 followed by
assessment in the order of (a) anthropometry (including
bioimpedance), fasting biochemistry, an oral glucose toler-
ance test, and assessment of CRF (V˙O2 peak) at University
Hospital Aintree and (b) MRI and proton MRS (1H-MRS) at
the University of Liverpool MRI Center. Because of the MRI
scanner replacement during part of this study, MRI quantifi-
cation of body fat was conducted in only 72 individuals.
Bioimpedance data were collected in all individuals, and V˙O2
peak calculations were based on both total body mass and fat-
free mass (FFM).
Individual Phenotyping
Individuals were characterized into one of four groups
based on BMI (nonobese, G30 kgImj2 vs obese, Q30 kgImj2)
and the presence or absence of METS according to Interna-
tional Diabetes Federation criteria; we refer to these groups as
(i) ‘‘nonobese METSj,’’ (ii) ‘‘nonobese METS+,’’ (iii)
‘‘obese METSj’’ and (iv) ‘‘obese METS+.’’
Habitual Assessment
PA monitoring. Physical activity wasmonitored throughout
using a validated (29) SenseWear mini armband (BodyMedia
Inc., Pittsburgh, PA). Wear time (recorded as ~98%) was
monitored using SenseWear Professional software (version 8.0).
Data included the following: daily average step count, total
energy expenditure, active energy expenditure, and time
spent in levels of PA including: sleep, lying down, sedentary
(G1.5 METS), light (1.5–3 METS), moderate (3–6 METS),
vigorous (6–9 METS), and very vigorous (99 METS). A
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Microsoft Excel template, as previously described (30), was
used to determine how sedentary time (not including sleep)
was accumulated and provided information on the frequency
of bouts and the time accumulated in a given bout category
(G1 h: 1–5, 6–10, 11–20, 21–40, 41–60 min; 1–2 h: 61–80,
81–100, 101–120 min; 92 h: 121–140, 141–160, 161–180 min).
To examine ‘‘frequently broken’’ periods of sedentary time,
the given bout categories at the lower end (G1 h) were shorter
in duration. At the higher end (91 h), where fewer bouts are
recorded, the given bout categories are greater in duration.
Based on previous observations (31), this approach was
adopted to investigate ‘‘patterns’’ of sedentary time, that is,
the frequency with which sedentary time is interrupted (sed-
entary breaks) or the duration of uninterrupted periods of
sedentary time (sedentary bouts). Furthermore, moderate to
vigorous PA (MVPA) of bouts greater or less than 10 min
were determined.
Dietary analysis. Total energy consumption, carbohy-
drate, protein, and fat content were determined from 4-d
dietary records by a registered nutritionist (K.M.) using
Nutritics (Nutrition Analysis Software for Professionals;
https://www.nutritics.com/p/home).
Other Assessment Measures
Anthropometric measurements. Stature (Model 220,
Seca, Germany) and whole-body bioimpedance analysis
(Tanita, BC 420, DolbyMedical Stirling, UK) was conducted;
this provided total body mass, fat percentage, fat mass, FFM,
muscle mass, total body water, basal metabolic rate, bone
mass, and visceral fat indicator. Waist and hip circumference
measurements were taken in duplicate, and blood pressure
was determined from an average of three measures (Dinamap,
G & E Medical, USA).
Biochemical measurements. Blood samples were
collected and analyzed using the Olympus AU2700 analyzer
(Beckman Coulter, High Wycombe, UK) with standard pro-
prietary reagents as follows: glucose with hexokinase, total
cholesterol and high-density lipoproteinwith cholesterol esterase/
oxidase and triacylglycerol with glycerol kinase. Low-density
lipoprotein was calculated according to the Friedwald formula.
Insulin was measured using radio-immunoassay (Invitrogen,
UK). HOMA-IR was calculated using fasting glucose and
insulin concentrations.
Oral Glucose Tolerance Test. Following a 12-h fast,
blood samples were collected, a 75-g glucose drink was
consumed within 5 min and postingestion blood samples
were drawn at 30, 60, 90, and 120 min. Matsuda index was
calculated to estimate whole-body IS, and indices of
hepatic-IR and skeletal muscle IS were determined as pre-
viously described (32).
CRF. A V˙O2 peak cardiopulmonary exercise test was
performed on a treadmill (Model 77OCE; RAM Medisoft
Group, Manchester, UK) in a temperature-controlled room.
The cardiopulmonary exercise test provided breath-by-breath
monitoring and analysis of expiratory gases and ventilation
(LoveMedical Cardiopulmonary Diagnostics, Manchester, UK).
The modified Bruce protocol was employed, after an initial
2-min warm-up at 2.2 kmIhj1 on a flat gradient, stepwise
increments in speed and gradient were employed each
minute. V˙O2 peak was determined by exhaustion plus one
or more of: respiratory exchange ratio 91.15, heart rate
990% predicted maximum, plateau in V˙O2.
1H-MRS. Liver and skeletal muscle fat were determined
using a 1.5T Siemens Symphony MRI scanner as previously
described (33).
Statistical Analysis
All data were explored for normality using visual inspection of
frequency distribution, and logarithmically transformed where
appropriate. Given the small sample size, power achieved on
each test was assessed and ranged from 46% to 999%; 20 of
26 achieved at least 80% power. Age was analyzed using a
one factor between-groups ANOVA, whereby a significant
group effect was observed (P G 0.05). Between-group uni-
variate general linear models were conducted for all other
variables, with age as a covariate and Bonferroni correction
for multiple comparisons. Statistically significant interactions
were explored, and nominal P values reported. Univariate and
multivariate linear regressions were used to analyze compo-
nents of PA and fitness associated with liver fat. Decisions
were made a priori to include all variables reaching P G 0.1 in
univariate regression analysis alongside age and BMI in the
multivariate regression model. The statistical cutoff for in-
clusion in the final model is more stringent than often used to
guard against false discovery. The alpha level of statistical
significance was set at P G 0.05. Data are presented as mean
(95% confidence interval), unless stated otherwise. Transformed
data were back-transformed to original units. P value 91
rounded to 1.000.
RESULTS
Participant Characteristics
The numbers of individuals with each risk factor of METS
are summarized in Table 1, with the PA and CRF data of the
whole cohort combined. Calculated from their average of 4-d
MVPA (accumulated in bouts of 910 min), 61% of individuals
met the World Health Organization recommendations.
Metabolic Phenotyping
The significant differences between the groups_ components
of METS were in line with International Diabetes Federation
classification (Table 2). There was no significant difference be-
tween obese METSj and obese METS+ BMI (P = 0.712) but
nonobese METS+ BMI was 3 T 2 kgImj2 greater than
nonobese METSj (P = 0.003). In the general population,
MRS defined that liver fat 95.5% corresponds with the
prevalence of hepatic steatosis (34); 84 and 14 participants
had liver fat G5.5% and Q5.5%, respectively.
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Dietary Intake
Total energy consumption, carbohydrate, protein and fat
did not differ significantly between groups (P 9 0.05). Mean T
SD macronutrient percentages were 56% T 16% carbohy-
drate, 24% T 9% protein, and 20% T 7% fat.
CRF
Obese METS+ individuals had lower CRF than both
obese and nonobese METSj (P e 0.029; mean difference
Q7.5 mLIminj1Ikgj1) but not nonobese METS+ (P =
0.675; mean difference 5.9 mLIminj1Ikgj1) There was no
difference between both nonobese groups and obese METSj
(P Q 0.080) (Fig. 1A).
Multiorgan IS
Nonobese METSj individuals had greater Matsuda index
than nonobese METS+ (P = 0.012; mean difference, 2.0)
(Fig. 1B); there was no difference between obese METSj and
both METS+ groups (P Q 0.141). There was no group effect for
skeletal muscle IS index (P = 0.220). Hepatic-IR index was
greater in obese METS+ than nonobese METSj (Fig. 1C).
There was a significant group effect (P = 0.022) for HOMA-IR.
MRS Quantification of Liver Fat
Liver fat was higher in METS+ in both nonobese and
obese. Nonobese METSj individuals had 4.6% lower liver
fat than obese METS+ (P e 0.005) (Fig. 1D). Liver fat
percentage in nonobese METS+ was not different to either
obese group (P Q 0.794; mean difference, Q0.6%); and liver
fat percentage in obese groups was not statistically different
(P = 0.336; mean difference, 2.6%).
Levels of PA: Differences between the Four
Metabolic Phenotypes
Average daily steps. There was no group effect for
average daily steps (Fig. 2A).
Nonsleep sedentary time, lying time, and sleep
duration. Nonsleep sedentary time (Fig. 2B) was not dif-
ferent between nonobese groups (P = 1.000; 49 minIdj1I)
and obese groups (P = 1.000; 23 minIdj1I). Nonobese
METSj individuals had lower sedentary time than obese
METS+ (P = 0.04); there was no difference between obese
METSj and both METS+ groups (P Q 0.199). There was no
group effect for amount of time spent lying down (P =
0.080) or sleeping (P = 0.117).
TABLE 2. Clinical, metabolic, and body composition characteristics of participants categorized for obesity and subsequently according to METS.
Nonobese Obese
METSj (n = 62) METS+ (n = 11) P METSj (n = 12) METS+ (n = 13) P
Gender M, n = 30; F, n = 32 M, n = 9; F, n = 2 0.042* M, n = 5; F, n = 7 M, n = 8; F, n = 5 0.319
Age (yr) 34 (31–38) 49 (43–55) G0.0005* 45 (39–50) 46 (39–52) 0.902
Weight (kg) 70.8 (68.1–73.6) 80.8 (75.7–85.9) 0.045* 96.3 (85.2–107.4) 99.8 (91.7–107.9) 0.470
BMI (kgImj2) 24.1 (23.4–24.8) 26.9 (25.7–28.2) 0.018* 33.7 (30.6–36.7) 34.1 (32.6–35.6) 0.722
Components of metabolic syndrome
Waist circumference (cm) 85 (82–87) 98 (93–102) 0.005* 105 (96–115) 111 (106–116) 0.191
Systolic BP (mm Hg) 120 (117–123) 144 (137–151) G0.0005* 126 (117–135) 147 (135–158) G0.0005*
Diastolic BP (mm Hg) 75 (72–77) 95 (85–105) G0.0005* 77 (73–80) 90 (82–98) 0.001*
Fasting glucose (mmolILj1) 4.9 (4.8–5.0) 5.4 (5.1–5.6) 0.076 5.0 (4.7–5.2) 5.7 (5.0–6.4) 0.003*
Triacylglycerol (mmolILj1) 0.9 (0.8–1.1) 1.5 (1.0–1.9) 0.080 1.2 (0.6–1.7) 1.8 (1.3–2.4) 0.016*
HDL-cholesterol (mmolILj1) 1.8 (1.7–1.9) 1.7 (1.2–2.1) 0.527 1.6 (1.3–2.0) 1.3 (1.6–1.8) 0.133
MRI-derived body composition n = 48 n = 8 n = 8 n = 8
Total body fat (L) 21.3 (18.9–23.7) 25.8 (20.1–31.5) 0.164 39.6 (33.6–45.6) 39.1 (33.2–44.7) 0.882
Total SAT (L) 16.5 (14.2–18.8) 18.6 (13.1–24.1) 0.492 30.5 (24.7–36.3) 28.2 (22.7–33.8) 0.562
Total internal fat (L) 4.7 (4.1–5.4) 7.3 (5.7–8.9) 0.006* 9.2 (7.5–10.9) 8.5 (6.9–10.2) 0.552
Abdominal SAT (L) 4.5 (3.5–5.5) 5.7 (3.3–8.1) 0.374 9.7 (7.2–12.3) 12.1 (9.7–14.6) 0.162
VAT (L) 2.3 (1.9–2.8) 4.2 (3.1–5.2) 0.002* 5.2 (4.1–6.2) 5.7 (4.5–6.8) 0.490
VAT: abSAT ratio 0.6 (0.5–0.7) 0.7 (0.5–0.9) 0.333 0.6 (0.4–0.8) 0.6 (0.4–0.8) 0.793
Data shown are mean (95% CI) and P values between groups.
*P G 0.05.
SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; abSAT, abdominal SAT; 95% CI, 95% confidence interval.
TABLE 1. PA and CRF data, the number of risk factors of METS and liver fat in 98 individuals.
Mean T SD
Average daily wear time (%) 98 T 4
Average daily steps (steps per day) 10,939 T 3482
Daily nonsleep sedentary time (min) 605 T 125
Daily light PA time (min) 241 T 84
Daily MVPA time (min) 143 T 92
Daily lying time (min) 486 T 83
Daily sleep duration (min) 403 T 67
Daily metabolic equivalents (METS) 1.6 T 0.3
V˙O2 peak (mLImin
j1Ikgj1) 32.9 T 8.2
Risk Factors Classifications N (%)
Waist circumference (cm) G94 M/80 F
Q94 M/80 F
65 (66%)
33 (34%)
Triacylglycerol (mmolILj1) e1.7
91.7
83 (85%)
15 (15%)
HDL-cholesterol (mmolILj1) Q1.03 M/1.29 F
G1.03 M/1.29 F
91 (93%)
7 (8%)
Systolic BP (mm Hg) e130
9130
64 (65%)
34 (35%)
Diastolic BP (mm Hg) e85
985
74 (76%)
24 (24%)
Fasting glucose (mmolILj1) e5.6
95.6
88 (90%)
10 (10%)
Classification column for risk factors is listed as METSj (top) and METS+ (bottom).
HDL, high-density lipoprotein; BP, blood pressure; M, male classification; F, female
classification.
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Daily light PA time. There was no difference in daily
light activity between both nonobese groups (P = 0.711;
mean difference, 10 minIdj1) and both obese groups (P =
1.000; 9 minIdj1). However, both obese groups had less
light activity than both nonobese METSj (P e 0.015; mean
difference Q 69 minIdj1) (Fig. 2C).
FIGURE 2—Habitual PA and sedentary time, individual participant plots for: average daily steps (A), nonsleep sedentary time (G1.5 METS) (B), light
activity (1.5–3 METS) (C), moderate to vigorous activity (93 METS) (D), daily metabolic equivalents (METS) (E) and PA duration (F). Data are
presented as mean T SD. Gray circles, METSj; white circles, METS+; nonobese are grouped left and obese are grouped right. *P G 0.05 group
difference between BMI category, further group differences being given in the text.
FIGURE 1—Cardiometabolic phenotyping, individual participant plots for: V˙O2 peak relative to FFM (A), whole-body insulin sensitivity (B), hepatic insulin
resistance index (C) and liver intrahepatocellular lipid (IHCL) (D). Data are presented as mean T SD. Gray circles, METSj; white circles, METS+; nonobese
are grouped left and obese are grouped right. *P G 0.05 group difference between BMI category, further group differences being given in the text.
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Daily MVPA time. There was no difference between the
groups_ moderate to vigorous activity (P = 0.322) (Fig. 2D),
and no significant differences were found for the way in
which MVPA was accumulated for bouts of 10 min or more,
in either total minutes accumulated or percentage of the time
in relation to total MVPA.
Average daily METS and PA duration. Daily aver-
age METS (Fig. 2E) and PA duration (Fig. 2F) had sig-
nificant group effects (P G 0.0005 and P = 0.020,
respectively); for both measures, nonobese METSj had
greater values than both obese groups, but were not different
to nonobese METS+. Daily average METS in nonobese
METSj were 0.3 METS greater than both obese groups
(P G 0.0005). The same was observed for PA duration, with
nonobese METSj having greater duration that both obese
groups (P e 0.018; mean difference Q107 minIdj1). There
was no significant difference between obese METSj and
both METS+ groups for average daily METS and PA dura-
tion (P Q 0.079 and P Q 0.450, respectively).
Patterns of waking sedentary time. Analysis of
sedentary behavior was performed on waking sedentary time
examining the duration of sedentary time (Fig. 3A) and the
number of sedentary bouts (Fig. 3B) in a predetermined bout
category. There were no differences between the groups in
sedentary bout durations of G1 h or 92 h. However,
significant differences were apparent during bout durations
lasting between 1 and 2 h.
Duration. During bouts of 61 to 80 min, nonobese
METS+ accumulated 33 min more sedentary time per day
than nonobese METSj (3, 60; P = 0.013). During bouts of
81 to 100 min, METS+ obese accumulated 34 minIdj1 more
than obese METSj (6, 62; P = 0.018). During bouts of 101
to 120 min, obese METS+ accumulated 28 minIdj1 more
than obese METSj (5, 51; P = 0.018).
Number of bouts. As an average of 4 d, both METS+
groups accumulated one to two more long bouts (between 1
and 2 h) of sedentary behavior, compared with their METSj
counterparts. Considering bouts of 61 to 80 min, nonobese
METS+ had 0.5 more bouts per day (0.1–0.9; P = 0.012)
than METSj. Obese METS+ had 0.4 more bouts per day
(0.1–0.7; P = 0.019) than METSj of 81 to 100 min and 0.3
more bouts per day (0.1–0.5; P = 0.017) of 101 to 120 min.
Levels of PA (regression analysis). Univariable linear
regression analysis revealed that daily average steps, sed-
entary time, vigorous activity, METS, and V˙O2 peak were
all significantly associated with liver fat. Carried forward in
the multivariable analysis, three of these factors remained
statistically significant predictors of liver fat (Table 3).
Greater daily sedentary time is associated with higher liver
fat, while higher overall daily METS and V˙O2 peak are
associated with lower liver fat (Fig. 3). For a 1-h increase in
sedentary time, liver fat increased by 1.15% (1.14%–1.50%;
P = 0.036), whereas for a 1-mLIminj1Ikgj1 increase in
CRF (V˙O2 peak), liver fat reduced by 0.87% (0.25–1.50;
P = 0.007).
DISCUSSION
The results of this extensive phenotypic analysis of objec-
tive measurements of PA and sedentary behavior, metabolic
and body composition measurements (including MRS-derived
liver fat) in young-middle age adults demonstrate two key
messages. First, in this cohort, overall habitual PA was not
associated with different metabolic health status in individuals
of similar BMI, and the accumulation of sedentary time was
weakly associated with the presence of the METS. Second,
even in habitually active individuals, there is an association
between greater sedentary time and increased liver fat,
whereas the amount of MVPA appeared to have little
FIGURE 3—Nonsleep sedentary behavior, individual participant plots
for: duration of sedentary bouts (A) and number of sedentary bouts in
given bout category (B) between 1 and 2 h.Data are presented asmean T SD.
Gray circles, METSj;white circles, METS+; nonobese are grouped left and
obese are grouped right. *P G 0.05 group difference between BMI category,
further group differences being given in the text.
TABLE 3. Multivariate regression for liver fat percentage (%).
A Coefficient 95% CI P
Liver fat %
Age (yr) 1.00 1.00 to 1.02 0.343
BMI (kgImj2) 1.01 0.97 to 1.12 G0.0005*
Average daily steps (1000) j0.97 j0.89 to j0.97 0.103
Average daily sedentary time (h) 1.15 1.14 to 1.50 0.036*
Average daily vigorous activity (min) j0.01 j0.01 to 0.01 0.273
Average daily METS (0.1) j0.48 j0.13 to j0.56 0.012*
V˙O2 peak (mLImin
j1Ikgj1) j0.87 j0.25 to j1.50 0.007*
Liver fat data were transformed and analyzed using log10, the data presented here is
back transformed to original units.
*P G 0.05.
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independent association. These data highlight the potential
importance of sedentary behavior in determining optimal
metabolic health and liver fat.
It is recognized that greater sedentary time increases the
risk of becoming overweight/obese (35) and the risk of type
2 diabetes and cardiovascular disease, even after controlling
for MVPA (8,36). Although total volumes of habitual PA do
not explain metabolic health in this cohort, those with
METS shown some evidence of being more sedentary, with
a higher number of prolonged bouts of sedentary behavior
(between 1 and 2 h). Frequent breaks in sedentary time have
been shown to be beneficial to metabolic risk (31), health
(37) and liver fat (24). To our knowledge, there are no
studies which have investigated sedentary bouts greater than
1 h. Interestingly, an extra hour of sedentary time has been
associated with a 39% increased odds for METS (38) and
decreasing sedentary time accumulated in prolonged bouts
may have beneficial effects on BMI and waist circumference
(39). Further research at durations of 91 h may reveal insight
into the pattern in which sedentary time is accumulated and
METS. Even individuals who are physically active can still
spend a significant amount of their waking day sedentary
(termed previously as ‘‘sedentary exercisers’’ (40)), which is
associated with increased cardiometabolic risk. Taken to-
gether, these findings suggest that public health and chronic
disease prevention strategies that largely focus on MVPA
recommendations might benefit from new recommendations
regarding interruption of prolonged sedentary time, com-
plimentary to those of PA.
Numerous prospective studies have confirmed the rela-
tionship between PA and liver fat (5,41–44) and compliance
with national MVPA guidelines has been associated with a
lower odds of NAFLD (26). Furthermore, recent research in
a population-based sample of adults has shown that V˙O2
peak is strongly, inversely, and independently related to the
risk of liver fat (45). The results presented are in agreement
with previous research, greater levels of PA (here daily
METS) and higher CRF is independently associated with
lower levels of liver fat. Importantly, the associations be-
tween CRF and liver fat remained after adjustment for BMI;
not all studies have reported similar findings (46). The as-
sociation between sedentary time and liver fat is equivocal.
Some authors have found no associations between PA or
sedentary behavior and liver fat in 82 individuals (25,26).
Whereas others have concluded that PA and sedentary time
are indeed independently associated with the prevalence
of NAFLD (22,24). In inactive individuals, every hour of
sedentary time was associated with increases of 1.74 L of
total abdominal fat, 0.62 L of visceral fat, 1.14 L of sub-
cutaneous fat, and 1.86% liver fat (22). Direct comparisons
or broad conclusions are difficult due to differences in co-
horts and methodology. The findings of the current study
suggest that sedentary time has an independent effect on
liver fat in active adults; however, more data are required to
confirm this. Our results, demonstrating that every hour of
additional sedentary time translates to a 1.15% increase in
liver fat, can be put into context by comparing the effects
of a 4-wk aerobic cycling intervention in sedentary obese
men and women, where liver fat reduced by 1.7% (47).
The effects surgical, nutritional, lifestyle, or pharmaceutical
interventions aiming to reduce liver fat has been recently
reviewed (48).
This study uses objective monitoring of PA, gold standard
measurement of CRF and MRS-derived liver fat in young-
middle age adults, all of which are key strengths. The results
did not support any strong evidence for a beneficial associ-
ation of sedentary bouts G1 h or detrimental association of
92 h perhaps due to study limitations which include the
relatively small sample size. Further limitations include:
duration of PA assessment, themonitor used to assess sedentary
behavior (SenseWear does not determine postural differences),
the comparatively healthy habitual PA habits of the participants
which somewhat limits the external validity of the findings,
and the cross-sectional design which cannot determine cau-
sality. Noteworthy is the higher BMI in unhealthy nonobese
versus healthy nonobese which conforms to the association of
a greater BMI with greater metabolic risk. This difference
could not be controlled for because it was a component of our
grouping analysis but differences in age were statistically
controlled for. Although the present results demonstrate that
overall sedentary time needs to be considered independently
of PA, objective PA monitoring in a larger cohort with a
prospective design will be required, and future research should
further explore sedentary behavior patterns (i.e., amount of
sedentary breaks and duration of sedentary bouts). The
American Diabetes Association has recommended that adults
should ‘‘decrease the amount of time spent daily in sedentary
behavior’’ and that ‘‘prolonged sitting should be interrupted
with bouts of light activity every 30 min.’’ Importantly, these
recommendations are in addition to, not a substitute for, a
physically active lifestyle. A ‘‘cutoff’’ for harmful sedentary
behavior patterns (i.e., frequency/duration) has not been
defined in public health guidelines.
In summary, in habitually active adults, the amount of
sedentary time is associated in this single-measure observa-
tion with metabolic health and the quantity of liver fat. The
findings of this study highlight that public health policy
designed to optimize the benefits of PA may need to syn-
ergistically consider strategies to reduce sedentary behavior.
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